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A new strategy is described for the determination of amino acid sequences of unknown
peptides. Different from the well-known but often inefficient de novo sequencing approach,
the new method is based on a two-step process. In the first step the amino acid composition
of an unknown peptide is determined on the basis of accurate mass values of the peptide
precursor ion and a small number of accurate fragment ion mass values, and, as in de novo
sequencing, without employing protein database information or other pre-information. In the
second step the sequence of the found amino acids of the peptide is determined by scoring the
agreement between expected and observed fragment ion signals of the permuted sequences. It
was found that the new approach is highly efficient if accurate mass values are available and
that it easily outstrips common approaches of de novo sequencing being based on lower
accuracies and detailed knowledge of fragmentation behavior. Simple permutation and
calculation of all possible amino acid sequences, however, is only efficient if the composition
is known or if possible compositions are at least reduced to a small list. The latter requires the
highest possible instrumental mass accuracy, which is currently provided only by fourier
transform ion cyclotron resonance mass spectrometry. The connection between mass accuracy
and peptide composition variability is described and an example of peptide compositioning
and composition-based sequencing is presented. (J Am Soc Mass Spectrom 2004, 15, 703–714)
© 2004 American Society for Mass SpectrometryMass spectrometry as a tool for the determina-tion of the amino acid sequence (AAS) ofpeptides (called peptide sequencing) so far
has been employed basically in its form of nominal-
mass spectrometry rather than accurate-mass spectro-
metry [1, 2]. Algorithms for descrambling fragmenta-
tion patterns were mainly based on probability
functions and combinatorial calculations regarding an
assumed fragmentation mechanism, rather than on
evaluation of precise and accurate mass values of
precursor and fragment ions. Graph representations
were used to describe and perform peptide sequencing
based on non-accurate mass values [3–5] with reason-
able success, but additional neutral losses common in
peptide ion fragmentation are hard to include and
combinations thereof cannot fully be represented.
When instruments became more precise and more
accurate in mass determination, users and evaluation
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doi:10.1016/j.jasms.2004.01.007software tools to some extent started to include the first
and second digit of mass values to distinguish different
structural possibilities. Taking full advantage of exact
mass information in bioanalytical mass spectrometry [6,
7], however, is still in its infant state.
Fourier transform mass spectrometry provides high-
est mass resolving power, but instruments, so far, were
laborious to use and complicated in handling and data
evaluation. Only recently, FTMS became available in a
form as easy and efficient in operation as for example
quadrupole ion trap mass spectrometry. Accurate mass
values are now available in routine analytical labora-
tory work and certainly will dominate data evaluation
protocols in the near future.
One of the primary targets of bioanalytical mass
spectrometry is peptide sequencing for protein identi-
fication, protein characterization or functional proteom-
ics. Nature composes peptides of 20 different amino
acids while amino acids are composed of chemical
elements C, H, N, O, and S. Only two amino acids,
isoleucine (I/Ile) and leucine (L/Leu) have identical
elemental compositions while all others can be clearly
distinguished by their composition. Although aminor Inc. Received October 31, 2003
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(e.g., AY and PH, or PF and LM) can easily have the
same nominal mass, the probability of having the same
elemental composition (and thus the identical accurate
mass) is highly reduced. Taking advantage of the full
information contained in accurate mass values is cer-
tainly known to be useful [8–16], but has not been fully
exploited so far.
The purpose of this paper is to show the power of
accurate mass values in sequence determination, and to
define the requirements for a new analytical strategy
based on accurate-mass spectrometry, resulting in a
simplified and highly reliable spectrum interpretation
and peptide sequencing independent of protein data
base information.
De novo sequencing [17–22] has become a method of
prominent importance in the field of functional pro-
teomics. De novo sequencing is necessary because da-
tabase search procedures [23, 24] often fail if the pro-
teins are modified, unknown, mutated, artificially
created via, e.g., combinatorial techniques, are from
unknown species or cancerous cells [25]. In this case the
amino acid sequence of peptides has to be determined
without employing database searching procedures.
This procedure, called de novo sequencing, often works
reliably and fast, if peptides under investigation are
tryptic and thus have basic residues at the C-terminus.
They generally fail, however, if the cleavage enzyme is
unknown or peptides are not digestion products. Basic
residues (as strong proton acceptors) in the middle of a
peptide sequence almost regularly lead to highly com-
plicated fragmentation spectra which can be very diffi-
cult to interpret unequivocally. Several algorithms for
de novo sequencing were reported [17–22], but none of
them has been shown to be absolutely reliable and
efficient if MS-MS data were obtained from non-ideal
fragmentation processes. They use experience based or
learned information about fragmentation behavior of
peptides. Mass values are used with only limited de-
Figure 1. De novo sequencing scheme.
Figure 2. Composition-bamand for accuracy, and accurate mass values are typi-
cally not used as exclusion or inclusion criteria. Such
algorithms are complicated and sometimes slow in
processing speed. They are, on the other hand, highly
susceptible to failures based on misinterpretation of
complicated fragmentation processes. The process of de
novo sequencing is summarized in Figure 1.
In this paper a new strategy is reported for non-
database assisted peptide sequencing , which is based
on the determination of the amino acid composition in
a first step (Figure 2). In analogy to the term peptide
sequencing this step is called peptide compositioning or
peptide composition analysis. It is shown that the
interpretation of the fragmentation spectrum is very
simple and reliable, if the amino acid composition of the
analyte is known and the mass accuracy is high. This
second step (based on the first) is called composition-
based sequencing (CBS) or de compositione sequencing
as an approach different from de novo sequencing.
Determination of the composition is possible, if the
mass of the peptide is not too high, if the instrumental
mass accuracy is sufficient and in some cases only if
additional characterizing information is obtained, e.g.,
by employing hydrogen–deuterium exchange.
Experimental
Nomenclature for Amino Acid Compositions
Including Partial Sequence Information
In order to distinguish amino acid compositions (AAC)
from amino acid sequences (AAS), the following no-
menclature for AAC descriptors is suggested.
1. AAS of peptides on the basis of single letter codes are
usually described by using upper case letters directly
following each other from left to right in the se-
quence order beginning at the N-terminus and end-
ing at the C-terminus (e.g., RLV meaning H-Argi-
nine-Leucine-Valine-OH). To distinguish AAC from
AAS it is suggested that compositions instead should
be described by using indices for the number of
units, by using alphabetical order, and by enclosing
permutable (not position-defined) units in parenthe-
ses, brackets and braces. The AAC descriptor of the
above peptide would therefore be H(L1R1V1)OH
assuming that the peptide has an amine N-terminus
and an acid C-terminus.
2. Partial sequence information should be included in
the AAC descriptor by using nested and hierarchical
sequencing (CBS) scheme.sed
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N-terminus contains the composition (L1R1V1) and
the C-terminus contains the composition (C1D1E1),
while the rest of the peptide has the composition
(H1K1M1S1) would be described as
H (L1R1V1) (H1K1M1S1) (C1D1E1) OH.
Units in brackets have to be permuted completely for
listing all possible amino acid sequences for a given
composition. Another peptide for which (L1R1V1) and
(C1D1E1) are not necessarily terminal but possibly inter-
nal groups would instead be described by nested and
hierarchical parentheses and brackets as
H [ (C1D1E1) H1K1 (L1R1V1) M1S1] OH.
Alphabetical order should be used in this case regard-
ing the first unit of a group. In this case the two groups
are undefined in position within the rest of the peptide
but do not overlap. So six units in outer brackets are
permutable, two groups (each consisting of three units)
and 4 amino acids.
3. Variability in composition should be included in the
AAC descriptor by using slashes and for clarity
including the respective units in brackets. If in a
composition a unit N1 could as well be G2 and unit
Q1 could as well be G1A1 (due to isoelemental
composition) a valid AAC descriptor would be
H [ (A1G1/Q1) (G2/N1) H1K1M1S1] OH.
Acquisition of Accurate Mass Values by Mass
Spectrometry
Mass spectra were acquired by electrospray ionization
on a new Finnigan LTQ FT (Thermo Electron, Bremen,
Germany) hybrid instrument consisting of a linear
quadrupolar ion trap and a Fourier transform ion
cyclotron resonance mass spectrometer. Mass accura-
cies are specified by the manufacturer to be better than
2 ppm with external calibration carried out once a
week. In practice it was found that mass accuracies are
better than1 ppm if the ion spray is sufficiently stable.
A mass resolving power of 400,000 at m/z  400 u was
chosen, which corresponds to a mass resolving power
of 160,000 at m/z 1000 u in FT-ICR mass spectrometry.
Mass values were determined by the standard software
of the instrument, which is very similar in appearance
to the software of the LCQ or LTQ ion trap instruments
of the company, and were transferred to the Peptide
LEGO software through the Windows XP clipboard.
Calculation of Accurate Mass Values of Peptides
and Fragment Ions
All calculations of accurate mass values of peptide ions
and peptide fragment ions were performed using thecomputer program Peptide LEGO (copyright Bernhard
Spengler, 1996–2003) under Windows XP or Linux,
which is especially designed for the determination and
evaluation of accurate mass values of precursor ions
and possible fragment ions, elemental compositions
and amino acid compositions. Peptide composition
analysis, CBS, and manual de novo sequencing is pos-
sible with this program, based on the strategy described
in this paper.
Results and Discussion
The Example Peptide: Substance P
To show the power of accurate mass values and of the
described procedure, the peptide Substance P (Mmono 
1346.7281 u, [M  H]mono  1347.7354 u, 11 amino
acids, RPKPQQFFGLM-NH2) was chosen. The follow-
ing procedure was performed semi-automatically using
Peptide LEGO. At mass 1347 u the number of possible
AAC per peptidogenic elemental composition (PEC) is
in the range of 100 and the accuracy that would be
required to determine the PEC unequivocally from the
precursor mass alone is in the range of 20 ppb, as
described in the following.
The peptide Substance P has been the subject of
numerous fundamental investigations in the field of
peptide fragmentation mechanisms [28–32]. The frag-
mentation pattern of Substance P is especially compli-
cated because of the appearance of intense and numer-
ous internal fragment ions, because of sequence
repetitions and because of multiple possibilities of iso-
baric sequence doublets. As a result, sequencing of
Substance P, if handled as an unknown peptide, usually
does not lead to an unequivocal result, either by manual
approaches or by automatic algorithms, but to a large
number of possible structures. The following demon-
stration shows, that the determination of the correct
amino acid composition (AAC) results in a small num-
ber of ambiguities, while the subsequent sequence
analysis on the basis of the correct AA composition
easily gives the correct sequence result.
The prerequisite for AAC determination on the basis
of precursor and product ion mass values is to achieve
sufficient reliability and precision (i.e., sufficient accu-
racy) in the determination of these data. Today, only
fourier transform mass spectrometry is able to provide
mass accuracies in the range below 2 ppm using exter-
nal calibration. Using a combination of a quadrupolar
ion trap and a fourier transform ion cyclotron resonance
cell, MSn data can be acquired with high operational
simplicity using routine ion formation and fragmenta-
tion protocols established for ion trap mass spectro-
metry.
As an example of the usefulness of high mass accu-
racy in the determination of primary structure, the mass
region of smaller fragment ions of Substance P shall be
described. It was a matter of discussion earlier [28],
what the real nature is of fragment ions that appear at
e P (
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and a1. Employing hydrogen–deuterium exchange of
acidic protons, it was found that the number of ex-
changeable protons of these fragment ions does not
match the expected number. It was concluded that the
observed ions cannot be a3, a2, and a1 ions, but in fact
are either internal ions or some unexpected rearrange-
ment ions, while a-type ions 3 to 1 instead are missing.
The lack of formation of fragment ions a3, a2, and a1 was
especially surprising, since the complete list of fragment
ions a11 down to a4 were obtained in high intensity [28].
ESI-IT-FTMS of Substance P resulted in the spectrum
shown in Figure 3.
Today, using high-accuracy mass spectrometry, the
open question raised by MALDI-PSD-TOF mass spec-
trometry in year 1993 is easily solved. Looking at the
section of the product ion spectrum containing the
region of the expected a3 ion, as an example, (Figure 4)
mass determination unequivocally showed that the
observed fragment ion is an internal ion PQQ  (B6Y8)3
 1, not an internal ion KPQ  (B5Y9)3  1 or any other
possible internal ion or rearrangement product, and
that the expected n-terminal ion a3 is indeed completely
missing.
The Relation Between Peptide Ion Masses
and Composition
Peptide mass values are not dispersed homogeneously
across the complete mass range but are located in
clusters [26, 27] around a mean value of n * 1.000458
with n being a whole positive number. For the cluster of
Figure 3. ESI-IT-FTMS spectrum of Substancall possible peptide masses around mass 1005.46 u, as
an example, the distribution is shown in Figure 5.
Determination of the amino acid composition from the
experimentally determined accurate mass is much sim-
pler if the target mass is located in the boundaries of the
peptide mass distribution with only a low number of
possible amino acid compositions, compared to the case
that the target mass is located in the peak of the mass
distribution function. For all calculations in the follow-
ing, example mass values were therefore chosen from
the center of the distribution function in order to
describe the worst case with respect to variability of
compositions.
The variability of peptide compositions was deter-
mined as a function of the given accuracy of mass
determination. In the mass range typical for tryptic
peptides or, e.g., for MHC-restricted peptides [25] it
was found that mass accuracies of 0.1 to 1 ppm are
necessary to achieve the highest possible certainty in
determination of the amino acid composition.
Figure 6 as an example shows the number of possible
amino acid compositions of a peptide whose protonated
singly charged parent ion has a monomolecular mass of
1005.4433 u, if the ion mass was determined with
different accuracies. When determined with 0.1 ppm
accuracy the peptide ion mass points to a set of seven
possible amino acid compositions (AAC). This number
cannot be further reduced since all of the seven AAC
have the same elemental composition and thus the
same accurate mass. At 1 ppm accuracy five different
peptidogenic elemental compositions (PEC) can be
found within the boundaries of mass determination
RPKPQQFFGLM-NH2, Mmono  1346.7281 u)
product ion spectrum of Substance P.
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example. This example shows that the mass accuracies
available with state-of-the-art mass spectrometers lie
exactly within the areas of common analytical require-
ments and that there is still some room and need for
instrumental improvements.
The isobaric nature of different amino acid compo-
sitions is certainly a serious limitation of mass spectro-
metrical information obtainable even by an ideal instru-
ment. It is, however, demonstrated in this paper, that
using combinatorial logic, this limitation can typically
be overcome to a large extent.
Amino acid variability per elemental composition is
shown in Figure 7 as a function of peptide mass. For a
Figure 4. Section of ESI-IT-FTMS
Figure 5. Number of possible peptide amino acid compositions
in arbitrary units for the cluster around m/z  1005.46 u. A mass
value from the segment displayed highlighted was taken for the
following calculation.Figure 6. Number of possible amino acid compositions of pep-
tides for a given example mass of 1005.4433 u as depending on the
accuracy of mass determination. Calculations were performed
including all of the 19 amino acids A C D E F G H (I  L) K M N
P Q R S T V W and Y. Mass calculations correspond to the
monomolecular isotopomers of the singly positively charged
protonated peptides (C terminus -OH, N terminus -H).
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accurate masses fall into the maxima of the mass
distribution functions (see Figure 5), the numbers of
possible amino acid compositions per unique peptido-
genic elemental composition were calculated. The re-
sults show that for peptides composed of 8 to 10 amino
acids (masses around 1000 u) the numbers of possible
Table 1. Number of possible amino acid compositions (AAC)
and amino acid based (peptidogenic) elemental compositions
(PEC) of peptides for a given example mass of 1005.4433 u as
depending on the accuracy of mass determination
Accuracy [ ppm] # of AAC # of PEC
9 3927 not determined
8 3577 not determined
7 3480 not determined
6 3022 not determined
5 1962 19
4 1582 16
3 1449 9
2 868 7
1.4 314 6
1.3 314 6
1 293 5
0.9 293 5
0.8 69 4
0.7 69 4
0.6 27 3
0.5 20 2
0.4 20 2
0.3 20 2
0.2 20 2
0.1 7 1
Calculations were performed for the 19 amino acids A C D E F G H (I 
L) K M N P Q R S T V W and Y. Mass calculations correspond to the
monomolecular isotopomers of the singly positively charged proton-
ated peptides (C terminus OH, N terminus H).
Figure 7. Number of possible amino acid combinations for a
unique peptidogenic elemental composition. Plotted values are
those for selected accurate masses chosen from the maxima of the
mass distribution function.AAC per unique PEC are between 10 and 100. A
method for determination of the amino acid composi-
tion of such peptides should ideally be able to differen-
tiate between iso-PEC compositions.
The mass spectrometric goal (and limit) is to deter-
mine a unique PEC from the obtained experimental
mass values. Figure 8 shows the calculated dependence
of the accuracies of mass determination necessary for
achieving unique PEC, as a function of the peptide
mass. For nominal-mass intervals of 100 u, three to four
accurate mass values were arbitrarily chosen from the
maxima of the mass distribution functions (see Figure
5), and distances to nearest neighbors were calculated in
ppm units. The calculation indicates that determination
of the PEC of a peptide from the mass of the precursor
ion alone is possible up to a mass of ca. 300 u if the
instrumental accuracy is10 ppm (routinely obtainable
with e.g., a quadrupole time-of-flight instrument) and
up to a mass of ca. 700 if the instrumental accuracy is
1 ppm (routinely obtainable with an FT-ICR instru-
ment). Only with a (currently unavailable) instrumental
mass accuracy of0.1 ppm, the PEC of a peptide can be
determined directly from the precursor ion mass up to
a mass of ca. 1100 u. Even if the described calculation
does not take into account each possible neighborhood
of accurate masses it still shows the mean values of
accuracy needed for PEC determination as a function of
mass.
It has to be noted here that all calculations were
performed for singly charged peptide ions. For multiply
charged ions the mass limits for determination of
unique PEC have to be divided by the charge of the ion,
so that for example the mass limit for an instrumental
accuracy of 1 ppm is ca. m/z 700 u for a singly
charged ion while it is ca. m/z 350 u for a doubly
charged ion.
Figure 8. Calculated accuracies of mass determination required
to achieve unique peptidogenic elemental compositions (PEC), as
a function of peptide masses. Plotted values are those for selected
accurate masses chosen at the maxima of the mass distribution
function. The bar below the mass axis indicates the (complete and
preferred) mass range of peptides composed of eight amino acids.
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accurate precursor ion mass alone is sufficient for the
unequivocal determination of the PEC or AAC of
peptides up to mass 700 u, with currently available
instrumental accuracies. For peptides above mass 700 u
it is described in the following how accurate fragment
ion mass values can additionally be employed to still
identify the PEC.
Combination with MS-MS Data: Peptide
Compositioning
In this section it is shown that, in addition to the
accurate precursor ion mass, only a few accurate masses
of MS/MS fragment ions are necessary to obtain a
unique PEC and a small number of candidate AACs for
an unknown peptide.
The general strategy for this is to use an iterative
process consisting of basically three iteration tasks:
Task 1.
Determine the amino acid composition of a fragment
ion in the mass range of 300 to 400 u. In this mass
range the PEC can usually be determined un-
equivocally from the accurate mass if the instru-
mental accuracy is better than1 ppm (see Figure
8). Besides the PEC, the amino acid composition
often can be determined unequivocally as well
under these conditions. If there is more than one
candidate AAC for a determined PEC, the list of
these candidate AACs can be evaluated in terms
of ranges of appearance for each amino acid.
These ranges can be used as a criterion for the
following task.
Task 2.
Use the resulting AAC restriction (number or range
of numbers, respectively, of amino acids within
the candidate AACs) determined for the fragment
ion to restrict the possible numbers of amino acids
of the precursor peptide ion. For each type of
amino acids its number in the fragment (or its
minimum number within the list of candidate
AACs of the fragment, resp.) is taken as a mini-
mum condition for the precursor peptide. Using
the restricted range of AACs the list of possible
AACs of the peptide can be computed from its
accurate mass value. This typically leads to an
already limited number of possibilities.
Table 2. Observed, calculated and corrected mass values used f
external calibration, computation and peptide-internal fine calibra
Fobs [u] F

calc [u] Errorobs/calc
352.16610 352.165568 1.51
382.25662 382.256115 1.32
465.25049 465.249632 1.84
501.24631 501.245609 1.40
449.22259 449.221703 1.97Task 3.
From the list of candidate AACs of the peptide
determine the highest numbers of amino acids of
each type for the precursor and use them as
maximum restrictions for the next iteration. The
same fragment ion of task 1 can be evaluated
again using this new maximum condition, often
leading to a stronger restriction of candidate
AACs within a unique PEC of the fragment ion. If
the repeated evaluation of the fragment ion does
not lead to any modification of the restrictions, go
to another fragment ion and repeat tasks 1 to 3
until no further change in the list of possible AAC
of the precursor peptide is obtained.
It was found that using this three-step iteration
procedure the PEC of peptides can often be determined
unequivocally and the list of possible AAC can be
reduced to a small number, even if (for the given mass
range and instrumental accuracy) the AAC determined
from the accurate mass of the precursor ion alone is
rather ambiguous (see Figures 7 and 8). Additionally,
partial sequence information can be extracted from the
above procedure, on the basis of determination of
fragment type and composition of the evaluated frag-
ments. The probability of obtaining a unique PEC
depends on the mass of the peptide and the instrumen-
tal mass accuracy.
Determination of the AAC of Substance P. On the basis of
accurate MS-MS data, a list of product ion masses was
obtained. Isotopomeric patterns were evaluated to de-
termine the charge state of the observed fragment ions.
For the following determination of AACs, the pep-
tide was treated as a complete unknown. It was unde-
fined as well, whether the unknown peptide under
investigation was a C-terminal amide or acid. The
observed precursor ion m/z value was 674.37143 u for a
doubly charged ion [M  2H]2. The corresponding
observed m/z value for a singly charged ion [M  H]
would thus be 1347.73558 u.
Fragment ion signals were mass determined by
using the once-a-week external calibration of the instru-
ment. The partial list of observed mass values is shown
in Table 2. Additional internal fine calibration is de-
scribed further down.
The following steps were necessary to achieve the
final AAC information:
C determination as obtained on the basis of instrumental
respectively
] Fcorrected [u] Errorcorr/calc [ppm]
352.16552 0.14
382.25599 0.33
465.24972 0.19
501.24548 0.25
449.22185 0.32or AA
tion
[ppm
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Iteration task 1.
Fragment ion 352.16610 u (external calibration; final
internally calibrated mass value 352.16552 u)
was unequivocally identified by Peptide LEGO
as an internal b-type ion of composition (F2G1).
No other compositions are possible within 2
ppm accuracy of any fragment ion type y, a, or
b. With mass accuracies of less than 9 ppm the
identification would have been ambiguous,
since at mass 352.1689 u two a-type ion compo-
sitions exist, (F1M1T1) and (C1M1Y1), which are
8.9 ppm off the observed mass. A mass resolv-
ing power of 113,600 is necessary to resolve the
possible neighboring mass signals. It is obvious
that only FTMS is able to provide a reliable
result in this case.
Iteration task 2.
Using the minimum condition that the unknown
peptide contains at least one G and two F, the
number of possible AAC for mass 1347.73558
within 2 ppm accuracy reduced to 97 assum-
ing an amide peptide and another 74 assuming
an acid peptide. This corresponds to a reduction
of possibilities by two orders of magnitude
compared with the unconstrained calculation:
The number of all possible AAC for mass
1347.73558 within 2 ppm accuracy is 8648 as-
suming an amide peptide and 7535 assuming an
acid peptide.
Iteration task 3.
Since there is only one candidate AAC for fragment
ion mass 352.16610 u, iteration task 3 did not lead
to a further reduction of possibilities within this
iteration. The maximum condition was used for
the next iteration.
Second iteration:
Iteration task 1.
Fragment ion 382.25597 u was identified as a b-type
ion of composition (K1P1R1). Other possibilities
within 2 ppm accuracy would be a-type ion
composition (G1P1R1V1) or y-type ion composi-
tion (H1K1V1) (amide at C-terminus). No y-type
ion composition was found assuming a C-termi-
nal acid instead of an amide. The a-type ion was
rejected since its appearance is quite unlikely
without appearance of a corresponding b-type ion
(m/z 410 u). The possible y-type ion was rejected
since an amide-type y-ion should be accompanied
by appearance of a y-NH3 ion (m/z 365 u) which
was not observed. Therefore (K1P1R1) was in-
cluded in the minimum condition of AAC of the
unknown peptide.Iteration task 2.
Using these constraints, m/z value 674.37143 u (dou-
bly charged precursor ion) or 1347.73558 u (recal-
culated singly charged precursor ion) resulted in
19 possible AAC assuming an amide peptide and
another two possible AAC assuming an acid
peptide.
Iteration task 3.
Since there is only one candidate AAC for fragment
ion mass 382.25597 u, iteration task 3 did not lead
to a further reduction of possibilities within this
iteration. The maximum condition was used for
the next iteration.
Third iteration:
Iteration task 1.
Evaluation of observed fragment ion 465.24973 u
resulted in the b-type ion composition possibili-
ties (A1F2V1) and (F2G1L1), the y-type ion compo-
sition possibility (K1M1S1T1) and the a-type ion
possibility (F2P1T1).
Iteration task 2.
Using (K1M1S1T1) or (F2P1T1) as an additional mini-
mum constraint in the determination of AAC of
the unknown peptide resulted in zero possibili-
ties, thus the fragment ion 465.24973 u cannot be a
y- or a-type ion but has to be a b-type ion (internal
or n-terminal). Using (A1F2V1) or (F2G1L1) as
additional constraints in the determination of
AAC of the unknown peptide reduced the list of
possible compositions from 19 to 14 (amide pep-
tides) and from two to one (acid peptide). The list
of remaining possibilities of AAC of the unknown
peptide is:
H (A3F2G2K1M1P2R1V1) NH2
H (A2F2G3K1L1M1P2R1) NH2
H (A2F2G1K1L1M1N1P2R1) NH2
H (A2F2G1K1M1P2Q1R1V1) NH2
H (A1F2G2K1L1M1P2Q1R1) NH2
H (A4C1F2G1K1L1P2R1) NH2
H (A2C1F2G2K1P2R1V2) NH2
H (A1C1F2G3K1L1P2R1V1) NH2
H (C1F2G4K1L2P2R1) NH2
H (F2G1K1L1M1P2Q2R1) NH2
H (A1C1F2G1K1L1N1P2R1V1) NH21
H (A1C1F2G1K1P2Q1R1V2) NH2
H (C1F2G2K1L2N1P2R1) NH2
H (C1F2G2K1L1P2Q1R1V1) NH2
H (F2G1H1K2L1M1P1R1S1) OH
Iteration task 3.
Iteration task 3 did not lead to rejection of possible
AACs (A1F2V1) or (F2G1L1) of fragment ion
465.24973 u within this iteration. The maximum
condition was used for the next iteration.
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Iteration task 1.
Using this list of possible AAC of the unknown
peptide, the observed fragment ion at 501.24547 u
was evaluated. No possible y-type ions (amide or
acid type) and no possible a-type ions were found
within 2 ppm deviation. The four possible b-
type ions (internal or n-terminal) are (A2F1G2P1),
(A2F1N1P1), (A1F1G1P1Q1), and (F1P1Q2).
Iteration task 2.
The list of possible AAC of amide peptides thus
reduces to the following 8 AACs:
H (A3F2G2K1M1P2R1V1) NH2
H (A2F2G3K1L1M1P2R1) NH2
H (A2F2G1K1L1M1N1P2R1) NH2
H (A2F2G1K1M1P2Q1R1V1) NH2
H (A1F2G2K1L1M1P2Q1R1) NH2
H (A2C1F2G2K1P2R1V2) NH2
H (F2G1K1L1M1P2Q2R1) NH2
H (A1C1F2G1K1P2Q1R1V2) NH2
all of them having the same elemental composition
of C63 H98 N17 O14 S1.
No possible AACs for fragment ion 501.24547 u were
found when assuming that the unknown peptide
is an acid peptide. Therefore at this stage it is
definite, that the peptide is an amide peptide
(neglecting other possible modifications).
The resulting list of 8 possible AAC of the unknown
peptide can be combined in terms of common
components to the AAC descriptor: H {K1R1F2 P2
[(A1V1M1)/(G1L1M1)/(V2C1)] [(G2A2)/(N1A2)/
(G1A1Q1)/(Q2)]} NH2, with units separated by
slashes being interchangeable.
Iteration task 3.
Iteration task 3 did not lead to rejection of possible
AACs (A2F1G2P1), (A2F1N1P1), (A1F1G1P1Q1), or
(F1P1Q2) of fragment ion 501.24547 u within this
iteration.
This final list cannot be further reduced without
employing additional methods, due to the isobaric
nature of the pairs (Q/GA), (N/GG), (VC/AM), and
(GL/AV). Still this short list of eight possible AACs can
easily be used to determine the most probable amino
acid sequence, as shown in the section on composition-
based sequencing.
Employing H/D exchange and exchangeable hydrogen
analysis. If it is necessary to achieve a unique AAC,
an extremely useful method for obtaining further
information to reduce the list of possibilities of AAC,
hydrogen– deuterium exchange can be employed [28]
as a very simple, quick, reversible, and sensitive
method of sample derivatization. Determination of
the number of exchangeable hydrogens using thismethod in the example of the above peptide leads to
a reduction of possible AAC to only the two matching
compositions
H (F2G1K1L1M1P2Q2R1) NH2
and
H (A1C1F2G1K1P2Q1R1V2) NH2,
having 23 exchangeable hydrogens, as measured. These
two possibilities can easily be distinguished by evalu-
ating fragment ion 449.22186 u, leading to possible
AACs of b-type (F1G1L1M1) or (C1F1V2) as a subset of
the two possible peptide compositions. While
(F1G1L1M1) contains five exchangeable hydrogens,
(C1F1V2) contains six exchangeable hydrogens. With the
additional information obtained by hydrogen–deute-
rium exchange, therefore, the amino acid composition
of the unknown peptide can unequivocally be deter-
mined to
H (F2G1K1L1M1P2Q2R1) NH2
which is indeed the composition of Substance P.
Internal fine calibration procedure. The mass accuracy of
the Finnigan LTQ-FT instrument is specified as being
better than 2 ppm. As can be seen from Table 2 all of
the values used for the AAC determination procedure
lie well within these limits. It is, however, obvious that
external calibration at the time of measurement was
already shifted systematically, since all deviations have
positive values above 1 ppm. It is, therefore, reason-
able to employ an additional fine tuning procedure to
shift values back to an averaged situation. Since mass
and frequency are linearly correlated in FT-ICR mass
spectrometry, a linear shift of mass values should
already lead to a considerable improvement of mass
accuracy. This shift can be controlled peptide-inter-
nally, by using the exact calculated mass values of
unequivocally defined PEC of the peptide fragments. In
the first step of determining the AAC of the peptide under
investigation, evaluating mass value 352.1661 u, the in-
strumental external calibration was used. The determined
PEC and AAC resulted in a calculated mass value of
352.165568 u. The shift between observed and calculated
mass value was used to define a first correction factor of
0.999998489. Evaluating the second fragment ion mass
value in the following step was performed using the
corrected mass values, and the determined PEC mass
value was used together with the calculated mass of the
first fragment to form a second order, averaged correction
factor. After evaluating all of the listed fragment ions, a
final averaged correction factor of 0.999998350 resulted in
errors of the corrected versus the calculated fragment ion
masses well below 0.4 ppm.
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As soon as the amino acid composition of the target
peptide is determined or the list of possible composi-
tions is reduced to a low number, possible amino acid
sequences (AAS) can be assessed by appropriate algo-
rithms.
The number of possible AAS (i.e., number of possible
peptides) is v  nk where v  the number of variations
(number of possible sequences), k  peptide length
(number of amino acid positions) and n  number of
different amino acids. For a peptide of unknown amino
acid composition and a length of 8 amino acids, the
number of possible sequences is thus v  208  2.56 *
1010.
This is a number of list components which can
typically not be computed and assessed in reasonable
time by standard computers. If, on the other hand, the
amino acid composition is known, the number of pos-
sible sequences is only P  k! where P  the number of
permutations (number of possible sequences for a given
AAC) and k  the peptide length (number of amino
acid positions). For the same peptide length of eight
amino acids, the number of possible sequences then is
only P  8!  40320.
It is obvious that this number of possibilities can
easily be computed in short time by regular computers.
Therefore in this example, accurate mass determination
results in a reduction of computing time by a factor of
634,920 when compared with permutation based de
novo sequencing. This might be quite astonishing and
certainly has not been realized to its full extent so far.
Having the amino acid composition of the target
peptide in hand, the number of sequences to be tested is
40320 for a 8 AA peptide and 39,916,800 for a 11 AA
peptide like Substance P. This number can be further
reduced if (as in the case of Substance P) several amino
acids are present in multiple copies. Including MS-MS
preinformation obtained for certain fragments as de-
scribed above, can be used to group several amino acids
within the permutation procedure, which reduces the
number of permutations considerably. Assuming, for
example, that the fragment identified as composition
(K1P1R1) is an N-terminal ion (rather than an internal
ion) reduces the number of permutations (sequences to
be assessed) from 11!  39,916,800 to P  3! * 8! 
Table 3. Weighting factors used to score sequences
Fragment ion type a, b, y
Fragment ion type z, b  H2O
Fragment ion type c, d, d, x
Fragment ion type v, w, w
Internal fragment ion
Neutral losses (NH3, H2O, ..)
Ratio of numbers of explained observed ions and theoretical
Ratio of numbers of explained observed ions and observed io
The score factor for each possible sequence was calculated by averagin
by multiplying the result by 100 and by the two number ratios.241,920 for the AAC descriptor H-(K1P1R1)(X8)-NH2
with X denoting various amino acids.
Assuming that the same fragment is an internal ion
rather than an N-terminal ion results in
P  3! * 9!  2,177,280 permutations for the AAC
descriptor H- [(K1P1R1)X8]-NH2.
Another (non-overlapping) group like (F2G1), as-
sumed to be an internal ion, results in P (3!/2!) * 3! *7!
 90,720 permutations for the corresponding AAC
descriptor H-[(K1P1R1)(F2G1)X5]-NH2.
The remaining units contain a Q doublet, which
reduces the number of permutations to P  P/2 
45,360 for the corresponding AAC descriptor
H-[(K1P1R1)(F2G1) L1M1P1Q2]-NH2.
Without performing further groupings, this number
of possibilities can already be computed easily in rea-
sonable time. Using accurate masses within an uncer-
tainty limit of 2 ppm, it was found that finding the
correct sequence out of all possible sequences is a rather
simple goal. A very simple algorithm is currently used
in Peptide LEGO ignoring any experience-based or
rule-based validation steps and any intensity correla-
tions. Peptide LEGO permutes possible sequences on
the basis of the determined AAC or the list of possible
AAC. For each sequence tested, Peptide LEGO simply
counts the number of hits when comparing theoretical
and observed fragment ion mass signals within the
chosen uncertainty limit. Each hit is weighed with a
fragment-type specific factor, so that for example inter-
nal ions are taken less important than N- or C-terminal
ions. Weighting factors used are listed in Table 3. With
this simple algorithm, theoretical fragment ion masses
of all 45,360 possible sequences for the determined AAC
were calculated and were compared to the list of
observed fragment ion masses. When starting with the
correct AAC of Substance P, Peptide LEGO found the
correct sequence RPKPQQFFGLM-NH2 of the peptide
as the first hit within seconds. Thus in combination with
hydrogen–deuterium exchange, the sequence of Sub-
stance P, when treated as an unknown peptide, can be
found easily with high confidence.
Without additional information about the number of
exchangeable hydrogens, eight possible AAC remained.
Testing all of the eight compositions led to the correct
sequence of the correct composition of Substance P, and
1.0
0.5
0.1
0.05
0.3
0.5 .. 0.05
ber of calculated ions Nexplained-observed/Ntheoretical
Nexplained-observed/Nobserved
applicable weighting factors for each explained observed fragment ion,num
ns
g the
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approach of Peptide LEGO. The scoring results for the
top scored AACs are shown in Table 4. Including
intensity information and intensity assumptions, or
including charge location expectations, however, would
easily improve the confidence of the results further, but
appears to be unnecessary at least for the given exam-
ple.
The procedure described in this paper was used to
test other peptides of lengths between eight and ten
amino acids. In all cases unequivocal results were
obtained for the list of possible AAC and for the
sequence. There is no doubt that future sequencing
algorithms based on peptide amino acid composition
analysis (CBS) will result in considerably faster deter-
mination of the peptide sequence, compared with de
novo sequencing. To develop such algorithms is a
rather straight forward task for the near future. The
important result of this paper is that the determination
of the sequence is simple and reliable if the composition
is already known.
Finally it has to be noted that peptide composition-
ing can be useful for sequence determination of much
larger peptides as well. Even if it is not possible to
determine a unique AAC of a large peptide, future
sequencing programs could still make use of range
information determined from longer lists of candidate
AACs and use these restrictions for improved scoring in
de novo sequencing.
Conclusions
High mass accuracy as available from state-of-the-art
mass spectrometers such as linear trap-Fourier trans-
form ion cyclotron resonance hybrid mass spectrome-
ters has been shown in this paper to provide a new
quality of structural information in mass spectrometry,
when employed to determine the amino acid sequence
of completely unknown peptides. Determination of the
amino acid composition in the first step was found to be
the major task and is possible for medium size peptides
when including high accuracy MS-MS data. Subsequent
Table 4. List of top scored sequences for each of the final eight
H {K1R1F2 P2 [(A1V1M1)/(G1L1M1)/(V2C1)] [(G2A2)/(N1A2)/(G1A
Score
[arbitrary
units]
Number of equally
scored sequences
Sequence (exampl
sequence in italics, re
0.1820 1 RPKPQQFFGLM-NH2
0.1607 4 RPKPQGAFFGLM-NH2
0.1473 1 RPKNAAPFFGLM-NH2
0.1425 9 RPKAPGGAFFGLM-NH
0.1396 1 RPKPQAGFFVAM-NH
0.1295 1 RPKAPGAGFFVAM-N
0.0760 11 RPKGPAAGFFVCV-NH
0.0810 2 RPKGPQAFFVCV-NH2
“Score” is a relative value resulting from the scoring process as describ
sequences having the same AAC were scored with the same scoring va
mass accuracy of 2 ppm.peptide sequencing is a rather simple task which can
easily be performed by error-proof permutation based
scoring algorithms.
The present study on the other hand shows that high
mass accuracy and high mass resolution is of great
importance for sequencing of unknown peptides or for
structure analysis of other biopolymers. The complexity
of operation of existing FT-ICR instruments until re-
cently had resulted in mixed opinions about the neces-
sity and appropriateness of accurate mass determina-
tion with this technique. Despite the fact that the utility
and value of accurate mass determination has been
recognized for some time, there was limited yearning to
make use of it. With the advent of a new generation in
technology, for example with the combination of FT-
ICR mass spectrometry with quadrupolar ion trap tech-
nology controlled by user friendly software, this has
changed considerably. Accurate mass values and high-
est mass resolution are now available in combination
with the most simple instrument handling and high
sample throughput. The ready availability of highly
accurate mass values now appears to provoke the
development of intelligent software that makes use of
this new dimension of structural information.
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